Vaccine Info


Authored by
Last reviewed
September 20, 2022

COVID-19 In 2022

During the COVID-19 pandemic, the U.S. FDA has Approved and Authorized various vaccines, antivirals, and monoclonal antibody therapies to prevent and treat people infected with the SARS-CoV-2 coronavirus that causes COVID-19.

COVID-19 Vaccines 

The U.S. Food and Drug Administration (FDA) Approved two COVID-19 vaccines and issued various Emergency Use Authorizations. The initial FDA Approval was for the Pfizer-BioNTech Comirnaty vaccine on August 23, 2021, followed by Moderna's SpikeVax vaccine on February 4, 2022.

And the FDA Authorized the Jcovden COVID-19 vaccine from Janssen - Johnson & Johnson on February 27, 2021, then on July 13, 2022, the FDA Authorized the Novavax COVID-19 Vaccine (Nuvaxovid™).

The U.S. CDC reported on September 14, 2022, that about 67.7% of the U.S. population had been 'fully vaccinated' with an Approve/Authorized COVID-19 vaccine, and about 48.6% of eligible people have been 'boosted' with a third vaccination. And 1.19 million children < 5 years of age had at least one dose since June 18, 2022.

On September 13, 2022, the CDC's Clinician Outreach and Communication Activity Call reviewed: Recommendations for Bivalent COVID-19 Booster Doses in People Ages 12 Years and Older.

COVID-19 Antivirals

The U.S. FDA has Approved and Authorized various antivirals (oral and IV) to treat COVID-19 infections. 

COVID-19 Monoclonal Antibody

The U.S. FDA has Authorized various monoclonal antibody therapies during the COVID-19 pandemic.


On September 1, 2022, the U.S. CDC Advisory Committee on Immunization Practices conducted a digital meeting. The presentations are posted on this CDC webpage.

The Vaccine Adverse Event Reporting System is a passive reporting system, meaning it relies on individuals to send in reports of their experiences. Anyone can submit a vaccine side effect report to VAERS, including parents and patients. Search, text your zip code to 438829 or call 1-800-232-0233 to find COVID-19 vaccine, antivirals, or antibody locations, such as pharmacies.

Clinical Trials

No clinical trials found